| ANABOLICS 10th Edition W Llewellyn Molecular Nutrition 10, 820, 2010 | 92* | 2010 |
| Anabolic androgenic steroid-induced hepatotoxicity P Bond, W Llewellyn, P Van Mol Medical Hypotheses 93, 150-153, 2016 | 82 | 2016 |
| Use of arachidonic acid as a method of increasing skeletal muscle mass WC Llewellyn US Patent 6,841,573, 2005 | 37* | 2005 |
| Use of arachidonic acid as a method of increasing skeletal muscle mass WC Llewellyn US Patent 6,841,573, 2005 | 37* | 2005 |
| Use of arachidonic acid as a method of increasing skeletal muscle mass WC Llewellyn US Patent 6,841,573, 2005 | 37* | 2005 |
| Anabolic steroids reference manual WA Llewellyn Body of Science 2007, 47-69, 2007 | 28 | 2007 |
| Anabolics 2005 W Llewellyn Body of Science, 2005 | 18 | 2005 |
| Use of 5alpha-androstanediol or 5alpha-androstanedione to increase dihydrotestosterone levels in humans WC Llewellyn US Patent 6,242,436, 2001 | 18 | 2001 |
| Anabolics 2004, 2003-4 W Llewellyn Molecular Nutrition, 66-7, 0 | 14 | |
| Underground anabolics W Llewellyn, R Tober Molecular Nutrition LLC, 2010 | 12 | 2010 |
| William Llewellyn's anabolics W Llewellyn (No Title), 2017 | 11 | 2017 |
| Insulin W Llewellyn Anabolics, 2005 | 11 | 2005 |
| Anabolics 2004 W Llewellyn Molecular Nutrition, 2003 | 11 | 2003 |
| Anabolics 2004 W Llewellyn Molecular Nutrition, 2003 | 11 | 2003 |
| Adrenergically-mediated weight loss product WC Llewellyn US Patent 6,531,162, 2003 | 8 | 2003 |
| Use of 4-hydroxytestosterone to lower estrogen levels in humans W Llewellyn US Patent App. 10/163,107, 2003 | 6 | 2003 |
| ANABOLICS. Molecular Nutrition W Llewellyn | 5 | 2017 |
| Anabolics. Molecular Nutrition LLc: Jupiter W Llewellyn FL, 2009 | 5 | 2009 |
| Anabolics, Molecular Nutrition LLC W Llewellyn Jupiter, USA, 2009 | 5 | 2009 |
| Deca-durabolin (nandrolone decanoate) W Llewellyn Anabolics 2005, 109-12, 2005 | 5 | 2005 |
